OCS Heart

The only FDA approved technology for extracorporeal perfusion and preservation of donor hearts in the U.S.

The only FDA approved technology for extracorporeal perfusion and preservation of donor hearts in the U.S.

The OCS Heart is a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state. By monitoring key parameters of the functioning heart, physicians may use their medical judgement to assess a potentially suitable heart’s condition and viability.

OCS Heart Clinical Trial

OCS™ Heart is the only system used in DCD heart transplantation worldwide
US pivotal trial to evaluate the Organ Care System for use with unutilized donor hearts that may not meet current standard acceptance criteria for transplantation.
  • 75 patients were enrolled
 •Types of expanded criteria donor hearts used37% – Expected ischemic time >4 hours
31% – 20 or more mins of down time
28% – LVEF of 40-50%
13% – Older donors >55 years
  8% – Coronary artery disease
(31 patients had 2 or more indications)
UNOS data showed donor hearts used for the OCS Heart EXPAND Trial had been declined for transplantation on average 66 times by other transplant centers before reaching an OCS Trial Center Primary effectiveness endpoints:
– Patient survival at day-30 post transplant
– Absence of severe primary heart graft dysfunction (PGD) in the first 24 hours post-transplantation
Declined Hearts
UNOS data showed donor hearts used for the OCS Heart EXPAND Trial had been declined for transplantation on average 66 times by other transplant centers before reaching an OCS transplant center.

Locate An OCS Heart Center

The OCS Heart is FDA approved and indicated for expanded criteria donor hearts.**  The OCS Heart is CE marked and commercially available in Europe, Australia, Canada, Middle East and Asia.

University of Washington Medical Center

9725 3rd Ave NE #400
Seattle, WA 98115

(206) 598-3300

Duke University Hospital

10 Duke Medicine Circle
Durham, NC 27710

(919) 372-3345

Vanderbilt University Medical Center

1211 Medical Center Dr
Nashville, TN 37232

(615) 322-5000

Stanford University Hospital

300 Pasteur Drive
Stanford, CA 94305
(650) 723-5468

Advent Health

601 East Rollins Street
Orlando, FL 32803
(407) 303-6611

Abbott Northwestern Hospital

800 E 28th Street
Minneapolis, MN 55407
(612) 863-4000

New York Presbyterian/Columbia University Medical Center

622 W 168th Street
New York, NY 10032
(212) 305-2500

UW Health University Hospital

600 Highland Avenue
Madison, WI 53792
(608) 262-5420

St. Vincent Indianapolis Hospital

2001 W 86th Street
Indianapolis, IN 46260
(317) 338-2345

Massachusetts General Hospital

55 Fruit Street
Boston, MA 02114
(617) 726-2000

Cedars-Sinai Medical Center

8900 Beverly Blvd.
Los Angeles, CA 90048
(310) 423-2641

Tampa General Hospital

1 Tampa General Circle
Tampa, FL 33606
(800) 505-7769

Yale New Haven Hospital

20 York Street
New Haven, CT 06510

Columbia University Medical Center

177 Fort Washington Ave.
New York, NY 10032
(800) 227-2762

The Ohio State University Medical Center

410 W. 10th Ave.
Columbus, Ohio 43210
(614) 293-8000

St. Vincent Indianapolis Heart Center

2001 West 86th St.
Indianapolis, IN 46260
(317) 338-2345

Emory Transplant Center

1365 Clifton Road Northeast, Building B
Atlanta, GA 30322
(855) 366-7989

Mayo Clinic

4500 San Pablo Rd S
Jacksonville, FL 32224
(904) 956-3309

Medical College of Wisconsin

9200 W Wisconsin Ave.
Milwaukee, WI 53226
(414) 805-3666

Queen Mary Hospital, Hong Kong

Queen Mary Hospital Main Block, Pok Fu Lam Rd, Pok Fu Lam, Hong Kong

The Prince Charles Hospital, Brisbane, Australia

627 Rode Rd, Chermside QLD 4032, Australia

Fiona Stanley Hospital, Perth, Australia

11 Robin Warren Dr, Murdoch WA 6150, Australia

St. Vincent Hospital, Sydney, Australia

406 Victoria St, Darlinghurst NSW 2010, Australia

Vienna General Hospital (AKH), Vienna, Austria

Währinger Gürtel 18-20, 1090 Wien, Austria

Toronto General Hospital (UHN), Toronto, Canada

200 Elizabeth St, Toronto, ON M5G 2C4, Canada

Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic

9, Vídeňská 1958, 140 21 Praha 4, Czechia

Rigshospitalet, Copenhagen, Denmark

Blegdamsvej 9, 2100 København, Denmark

CHRU de Lille, Lille, France

2 Avenue Oscar Lambret, 59000 Lille, France

CCML, Paris, France

133 Avenue de la Résistance, 92350 Le Plessis-Robinson, France

Universitatsklinikum Essen, Germany

Hufelandstraße 55, 45147 Essen, Germany

Universitats Herzzentrum, Freiburg-Bad Krozingen, Germany

Südring 15, 79189 Bad Krozingen, Germany

Medizinische Hochsschule Hannover, Germany

Carl-Neuberg-Straße 1, 30625 Hannover, Germany

Ospedali Dei Colli, Naples, Italy

Via Gaetano Quagliariello, 54, 80131 Napoli NA, Italy

Ospedale Niguarda, Milan, Italy

Piazza dell'Ospedale Maggiore, 3, 20162 Milano MI, Italy

Azienda Ospedaliera di Padova, Padova, Italy

Via Nicolò Giustiniani, 2, 35128 Padova PD, Italy

Azienda Sanitaria Universitaria Integrata Di Udine, Udine, Italy

Via Pozzuolo, 330, 33100 Udine UD, Italy

National Research Cardiac Surgery Center, Astana, Kazakhstan

Turan Ave 38, Nur-Sultan 020000, Kazakhstan

King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Zahrawi St, Al Maather، Riyadh 12713, Saudi Arabia

Queen Elizabeth Hospital, Birmingham, UK

Mindelsohn Way, Birmingham B15 2TH, UK

Harefield Hospital, London, UK

Hill End Rd, Harefield, Uxbridge UB9 6JH, UK

Wythenshawe Hospital, Manchester, UK

Southmoor Rd, Roundthorn Industrial Estate, Wythenshawe, Manchester M23 9LT, UK

The Freeman Hospital, Newcastle, UK

Freeman Rd, High Heaton, Newcastle upon Tyne NE7 7DN, UK

Royal Papworth Hospital, Cambridge, UK

Papworth Rd, Trumpington, Cambridge CB2 0AY, UK

Golden Jubilee Hospital, Glasgow, Scotland

Agamemnon St, Clydebank G81 4DY, UK

The OCS Lung, OCS Heart and OCS Liver are all CE marked devices. The OCS Lung is an FDA approved device for standard and expanded1 criteria donor lungs. The OCS Heart is an FDA approved device for expanded2 criteria donor hearts. The OCS Liver is an FDA approved device for DCD3 and DBD donor Livers.

1. Expanded criteria lungs is defined as donor lung pairs initially deemed unacceptable for procurement and transplantation based on limitations of cold static preservation.
2. Expanded criteria hearts is defined as donor hearts that are deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of prolonged cold static cardioplegic preservation (e.g., > 4 hours of cross-clamp time).
3. DCD livers < 55 years old with < 30 mins warm ischemia time and macrosteatosis < 15%.
Only multi-organ platform used with donor lungs, hearts and livers
Largest user base at 70 leading US and global transplant centers
Largest body of literature and clinical evidence in warm perfusion
Most extensive training program including 24/7 clinical support
WordPress Lightbox